CME Sues CFTC Over Crypto Perpetual Futures Approval
CME Group challenges the CFTC in court over the approval of perpetual futures for Kalshi, sparking a major legal battle for U.S. crypto derivatives.
The world’s largest futures exchange has officially filed a lawsuit in a Washington federal court against the Commodity Futures Trading Commission (CFTC). The legal challenge disputes the regulator’s decision to allow companies like Kalshi to offer perpetual futures, a move that opens the door for broader U.S. investor access to crypto derivatives.
This case is being viewed as one of the most significant legal battles in the sector since the approval of spot Bitcoin ETFs. The outcome could determine whether crypto derivatives remain under the current regulatory regime or face significantly more stringent requirements.
CME Challenges CFTC Product Classification
CME’s primary argument centers on the claim that perpetual futures do not meet the traditional definition of a futures contract. Unlike standard contracts, these instruments lack an expiration date and do not involve the physical delivery of the underlying asset. The exchange contends that these characteristics make them more akin to swaps under the Dodd-Frank Act rules.
This distinction carries heavy weight beyond legal terminology. If these products are reclassified as swaps, participants would have to comply with much stricter capital and regulatory mandates, including longer collateral periods and additional registrations with regulators. CME alleges that the CFTC bypassed these requirements by treating the products as traditional futures.
Dispute Over the Approval Process
The second line of attack focuses on the regulatory approval process itself. CME claims the commission allowed these products through a self-certification procedure in just one day, bypassing public comment and a thorough analysis of potential market risks.
The exchange argues that such instruments could significantly impact the financial system and should not be approved via accelerated procedures. Consequently, the company is likely to seek a temporary injunction to block the offering of perpetual contracts until the lawsuit is resolved.
Regulator Sees an Attempt to Stifle Competition
The CFTC responded sharply, characterizing the lawsuit as an attempt to use the judicial system to protect CME’s dominant position in the derivatives market. According to the commission, the claim lacks legal merit and represents an effort to slow down innovation within the sector.
Companies set to benefit from the new rules shared this sentiment. Kalshi, whose product is at the heart of the dispute, stated that CME’s actions are motivated by a fear of competition. The company argued that investors should have access to regulated domestic markets rather than being forced onto offshore platforms.
The decentralized exchange Hyperliquid also criticized the legal move, stating it risks delaying the development of the American crypto market at a time when the rest of the world is accelerating the integration of digital assets.
The Future of Crypto Derivatives at Stake
This case unfolds against the backdrop of an increasingly favorable regulatory environment for the crypto industry in Washington. Both the Donald Trump administration and current CFTC leadership have expressed a desire for more crypto products to be offered within the U.S. financial system rather than on offshore markets.
This is precisely why Wall Street and the crypto sector are watching the case so closely. If CME successfully enforces its position, perpetual contracts could face a much stricter regime, increasing costs for operators and potentially limiting their reach in the U.S.
Conversely, if the CFTC wins the dispute, it could trigger a wave of new crypto derivative products and accelerate the migration of this market back under U.S. regulatory jurisdiction. For an industry managing trillions of dollars in annual volume, the stakes involve more than a single product—it is about who defines the rules for the next generation of financial markets.

Fill in necessary fields and publish